Trial site
Glasgow
- 14running trials
- 3closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease3 trials
- Multiple sclerosis3 trials
- Prostate cancer3 trials
- Stroke3 trials
- Chronic myeloid leukaemia2 trials
- Neuroendocrine tumours2 trials
- ANCA-associated vasculitis1 trial
- Childhood cancers1 trial
- Familial hypercholesterolaemia1 trial
- Huntington's disease1 trial
- Immune thrombocytopenia (ITP)1 trial
- Myeloproliferative neoplasms1 trial
- and 1 more
- Phase
- Phase 311 trials
- Phase 23 trials
- Phase 11 trial
- Phase 41 trial
- Status
- Active, not recruiting10 trials
- Recruiting4 trials
- Completed2 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals16 trials
- Advanced Accelerator Applications1 trial
Running trials
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA
Active, not recruiting
Active, not recruiting
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
- Huntington's disease1 recruiting
- Multiple sclerosis1 recruiting
- Neuroendocrine tumours1 recruiting
- Prostate cancer1 recruiting
Closed trials
Terminated
Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026